In this study, we used a cut-off point of 20% events to define expression status as in previous studies [20, 21] but, no significant differences of antigen profile between APL and HLA-DR-negative AML was found (except CD56 and CD64, Additional file 5: Table S2). The gene discussed is FCGR1A; the disease is acute promyelocytic leukemia.